Literature DB >> 12932937

Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.

Francesco Montorsi1, Alberto Briganti, Andrea Salonia, Patrizio Rigatti, Alberto Margonato, Andrea Macchi, Stefano Galli, Paolo M Ravagnani, Piero Montorsi.   

Abstract

OBJECTIVES: The aim of this study was to assess erectile dysfunction prevalence, time of onset and association with risk factors in patients with acute chest pain and angiographically documented coronary artery disease.
METHODS: 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease were assessed using a semi-structured interview investigating their medical and sexual histories, the International Index of Erectile Function and other instruments.
RESULTS: Patient mean age was 62.5+/-8 years (range 33-86 years). Mean duration of symptoms or signs of myocardial ischaemia prior to enrollment in the study was 49 months (range 1-200). Coronary angiography showed 1-, 2- and 3-vessel disease in 98 (32.6%), 88 (29.3%) and 114 (38%) patients, respectively. The prevalence of ED among all patients was 49% (147/300). Erectile dysfunction was scored as mild, mild to moderate, moderate and severe in 21 (14%), 31 (21%), 20 (14%), and 75 (51%) of patients, respectively. There was no significant difference between patients with ED (n=147) or without ED (n=153) as far as clinical and angiographic characteristics were concerned. In the 147 patients with co-existing ED and CAD, ED symptoms were reported as having become clinically evident prior to CAD symptoms by 99/147 (67%) patients. The mean time interval between the onset of ED and CAD was 38.8 months (range 1-168). There was no significant difference in terms of risk factor distribution and clinical and angiographic characteristics between patients with the onset of ED before vs. after CAD diagnosis. Interestingly, all patients with type I diabetes and ED actually developed sexual dysfunction before CAD onset (p<0.001).
CONCLUSIONS: Our study suggests that a significant proportion of patients with angiographically documented coronary artery disease have erectile dysfunction and that this latter condition may become evident prior to angina symptoms in almost 70% of cases. Future studies including a control group of patients with coronary artery disease and normal erectile function are required in order to verify whether erectile dysfunction may be considered a real predictor of ischemic heart disease.

Entities:  

Mesh:

Year:  2003        PMID: 12932937     DOI: 10.1016/s0302-2838(03)00305-1

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  95 in total

1.  Erectile dysfunction: a vascular disease in the field of urology.

Authors:  Francois Bénard
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 2.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

3.  Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.

Authors:  G Corona; E Mannucci; A D Fisher; F Lotti; E Bandini; L Vignozzi; G Balercia; F Paggi; L Petrone; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

4.  Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study.

Authors:  Shua J Chai; Elizabeth Barrett-Connor; Anthony Gamst
Journal:  Atherosclerosis       Date:  2008-08-07       Impact factor: 5.162

5.  Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses.

Authors:  Martin Reriani; Andreas J Flammer; Jing Li; Megha Prasad; Charanjit Rihal; Abhiram Prasad; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-11       Impact factor: 1.439

Review 6.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

7.  Endovascular therapy for vasculogenic erectile dysfunction.

Authors:  Jason H Rogers; Krishna J Rocha-Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

Review 8.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

9.  Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction.

Authors:  Ridwan Shabsigh; Joel Kaufman; Michelle Magee; Dana Creanga; David Russell; Meeta Budhwani
Journal:  BMC Urol       Date:  2010-11-05       Impact factor: 2.264

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.